This is a builder's course for the ambulatory practice. One composite organization runs through it: Ashcombe Medical Group, 16 providers in family medicine and orthopedics across three Pennsylvania sites, whose partners approved a $720,000 AI plan on a managing partner's promise of $1.2 million a year in net benefit. Each module solves one of Ashcombe's problems and ends in a Decision Lab: deciding how four vendors connect to the PM and EHR (a certified FHIR API reads but cannot book; a shared login is the fast option and the wrong one); answering every call with an AI voice agent and scoring its log by caller language; extracting faxed referrals without filing them to the wrong patient, and routing 42 CFR Part 2 pages; choosing between an EHR-native and a third-party ambient scribe on the practice's own notes, in a state that requires every party's consent to record; keeping eligibility summaries, AI code suggestions and the post-scribe E/M shift honest; and running an AI inventory that finds the features nobody switched on knowingly.
Real products (athenahealth, Epic, eClinicalWorks, NextGen, ModMed, Microsoft Dragon Copilot, Assort Health, Phreesia, Tennr and others) are compared the way practices choose them in October 2026, with every vendor figure treated as a claim, and the randomized trials of ambient scribes used as the evidence. The controls are taught where they bite: HIPAA business associate, minimum-necessary, audit-control and risk-analysis rules; the certified API criterion and information blocking; the TCPA and the FCC's ruling on AI voices; Section 1557 language access and decision-support duties; 42 CFR Part 2; No Surprises Act good-faith estimates; ICD-10-CM, NCCI, the 60-day overpayment rule and the False Claims Act. The capstone is a go/no-go package for the partners, including the value bridge that separates cost removed, measured collections and capacity. Claims, denials and prior authorization in depth are in hls-255. Status is as of October 2026; the course is educational, not legal or coding advice, and no vendor endorses it.